New Covid-19 pill in Germany exceeds all expectations as it reduces Coronavirus deaths by half October 3, 2021 A new experimental Covid-19 pill reduced stays in hospital and deaths by half, according to German multinational science and technology company Merck. In fact, an independent group of medical experts that monitored the trial recommended stopping it early because the interim results were so strong, beating all expectations. The company said today it would soon [...]
Pfizer and Moderna down: Merck’s stock skyrockets after its new Covid antiviral pill smashes all expectations October 1, 2021 Shares in US science giant Merck are up by more than 10 per cent this afternoon after the company revealed a newly developed Covid-19 pill smashes all expectations. As a result, vaccine giants across the board are down, Pfizer by nearly 2 per cent, Moderna 4.7 per cent and Novavax dropped by 7.5%. The companies [...]
‘Your move, Mark’: After YouTube ban Facebook becomes primary anti-vaxx platform in the world October 1, 2021 As YouTube cracks down on anti-vax content, an activisit group has warned Facebook is now the main platform for spreading and sharing anti-Covid vaccine messages. The Center for Countering Digital Hate, which exposes accounts of individuals that share and spread anti-vaccine content circulating on social media, has called on Facebook to follow YouTube’s latest crackdown. The [...]
Jabs for young people set to give Britain even more protection October 1, 2021 | Sponsored The UK’s vaccine rollout has been a success story, allowing us to return to our normal lives. Across the country people have been enjoying catching up with friends and family and doing the things they love. The next step in the Government’s strategy for keeping us safe from Covid-19 is the roll-out of the vaccine [...]
Oxford Nanopore soars on London debut, touching £5bn September 30, 2021 Shares in genome sequencing company Oxford Nanopore rocketed as much as 45 per cent this morning after its IPO, in the best-ever London market debut for a company of its size. Oxford Nanopore shares were trading at 619p per share at market open, pushing its market cap up to £4.93bn – significantly higher than the [...]
Vaccine competition: Sanofi shelves mRNA-based Covid jab work September 28, 2021 French pharmaceutical giant Sanofi has shelved plans for its own mRNA-based Covid-19 jab due to the vaccine-success and dominance of rivals Pfizer and Moderna. Instead, Sanofi is set to focus on a different coronavirus vaccine making approach with its British partner GlaxoSmithKline (GSK). It signals the growing weight of the companies, namely BioNTech-Pfizer, Moderna and [...]
Covid-19 vaccine maker Oxford Biomedica posts “record” revenue surge September 22, 2021 Gene and cell therapy group Oxford Biomedica has recorded “record” results in the past six months, boosted by its Covid-19 vaccine manufacturing with AstraZeneca. Revenue surged 139 per cent to £81.3m in the six months to 30 June, from £34m in the same period last year – mainly due to its bioprocessing and commercial [...]
15,000 Brits who took part in Novavax trials unable to prove Covid vaccine status September 20, 2021 Ministers are being urged to help thousands of people who took part in Covid-19 vaccine trials who cannot prove their vaccination status. Trial participants have described being “trapped” and “in limbo” because they are unable to get a licensed Covid-19 vaccine or travel abroad. Around 15,000 Britons took part in the Novavax Covid-19 vaccine clinical [...]
Researchers study bats in remote part of Cambodia in search for Covid-19 origin September 20, 2021 Researchers are collecting samples from bats in northern Cambodia in a bid to understand the coronavirus pandemic, returning to a region where a very similar virus was found in the animals a decade ago. Watch the full report.
WHO appoints Gordon Brown as ambassador for global health financing September 20, 2021 The World Health Organisation this morning appointed former prime minister Gordon Brown an ambassador for global health financing. Brown has been campaigning tirelessly in recent months for wealthy nations and the private sector to ensure the equitable distribution of Covid-19 vaccines. He is calling for a concerted global effort to save lives, especially in poorer [...]